Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study

Health and Quality of Life Outcomes

Martijn A Spruit³  Frits ME Franssen³  Jos MGA Schols⁴  Emiel FM Wouters¹  Daisy JA Janssen²  Sarah Wilke³ 

[1] Department of Respiratory Medicine, Maastricht University Medical Centre+ (MUMC+), Maastricht, The Netherlands;Proteion Thuis, Horn, The Netherlands;Program Development Centre, CIRO+, centre of expertise for chronic organ failure, Hornerheide 1, Horn, NM 6085, The Netherlands;Department of General Practice and Department of Health Services Research, Faculty of Health, Medicine and Life Sciences/CAPHRI, Maastricht University, Maastricht, The Netherlands

关键词: Generic health status;    Disease-specific health status;    Health status;    St. George’s Respiratory Questionnaire;    Health-related quality of life;    Chronic obstructive pulmonary disease;   

Others  :  825251
DOI  :  10.1186/1477-7525-10-98

 received in 2012-03-13, accepted in 2012-08-16,  发布年份 2012

【 摘 要 】

Background

Longitudinal studies analyzing the correlations between disease-specific and generic health status questionnaires at different time points in patients with advanced COPD are lacking. The aim of this study was to determine whether and to what extent a disease-specific health status questionnaire (Saint George’s Respiratory Questionnaire, SGRQ) correlates with generic health status questionnaires (EuroQol-5-Dimensions, EQ-5D; Assessment of Quality of Life instrument, AQoL; Medical Outcomes Study 36-Item Short-Form Health Survey, SF-36) at four different time points in patients with advanced COPD; and to determine the correlation between the changes in these questionnaires during one-year follow-up.

Methods

Demographic and clinical characteristics were assessed in 105 outpatients with advanced COPD at baseline. Disease-specific health status (SGRQ) and generic health status (EQ-5D, AQoL, SF-36) were assessed at baseline, four, eight, and 12 months. Correlations were determined between SGRQ and EQ-5D, AQoL, and SF-36 scores and changes in these scores. Agreement in direction of change was assessed.

Results

Eighty-four patients (80%) completed one-year follow-up and were included for analysis. SGRQ total score and EQ-5D index score, AQoL total score and SF-36 Physical Component Summary measure (SF-36 PCS) score were moderately to strongly correlated. The correlation of the changes between the SGRQ total score and EQ-5D index score, AQoL total score, SF-36 PCS, and SF-36 Mental Component Summary measure (SF-36 MCS) score were weak or absent. The direction of changes in SGRQ total scores agreed slightly with the direction of changes in EQ-5D index score, AQoL total score, and SF-36 PCS score.

Conclusions

At four, eight and 12 months after baseline, SGRQ total scores and EQ-5D index scores, AQoL total scores and SF-36 PCS scores were moderately to strongly correlated, while SGRQ total scores were weakly correlated with SF-36 MCS scores. The correlations between changes over time were weak or even absent. Disease-specific health status questionnaires and generic health status questionnaires should be used together to gain complete insight in health status and changes in health status over time in patients with advanced COPD.

【 授权许可】

   
2012 Wilke et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
• [2]Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, Ostinelli J: Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 2011, 37:264-272.
• [3]Vaes AW, Wouters EF, Franssen FM, Uszko-Lencer NH, Stakenborg KH, Westra M, Meijer K, Schols AM, Janssen PP, Spruit MA: Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest 2011, 140:970-979.
• [4]Annegarn J, Meijer K, Passos VL, Stute K, Wiechert J, Savelberg HH, Schols AM, Wouters EF, Spruit MA: Problematic Activities of Daily Life are Weakly Associated With Clinical Characteristics in COPD. J Am Med Dir Assoc 2012, 13:284-290.
• [5]Curtis JR, Patrick DL: The assessment of health status among patients with COPD. Eur Respir J Suppl 2003, 41:36s-45s.
• [6]Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluna JJ, van der Molen T, Adamek L, Banik N: Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011, 105:57-66.
• [7]Janssen DJ, Spruit MA, Leue C, Gijsen C, Hameleers H, Schols JM, Wouters EF: Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010, 7:147-157.
• [8]Spruit MA, Pennings HJ, Janssen PP, Does JD, Scroyen S, Akkermans MA, Mostert R, Wouters EF: Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 2007, 101:2454-2463.
• [9]Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, Falzon C, Garrod R, Lee C, Polkey MI, et al.: The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011, 66:425-429.
• [10]Moullec G, Laurin C, Lavoie KL, Ninot G: Effects of pulmonary rehabilitation on quality of life in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2011, 17:62-71.
• [11]Nici L, ZuWallack R, Wouters E, Donner CF: On pulmonary rehabilitation and the flight of the bumblebee: the ATS/ERS Statement on Pulmonary Rehabilitation. Eur Respir J 2006, 28:461-462.
• [12]Spruit MA, Vanderhoven-Augustin I, Janssen PP, Wouters EF: Integration of pulmonary rehabilitation in COPD. Lancet 2008, 371:12-13.
• [13]Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, et al.: Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-469.
• [14]Patrick DL, Deyo RA: Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989, 27:S217-S232.
• [15]Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J, Aizpiri S, Aguirre U, Capelastegui A: Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010, 36:292-300.
• [16]Habraken JM, van der Wal WM, Ter Riet G, Weersink EJ, Toben F, Bindels PJ: Health-related quality of life and functional status in end-stage COPD: a longitudinal study. Eur Respir J 2011, 37:280-288.
• [17]Maly M, Vondra V: Generic versus disease-specific instruments in quality-of-life assessment of chronic obstructive pulmonary disease. Methods Inf Med 2006, 45:211-215.
• [18]Menn P, Weber N, Holle R: Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes 2010, 8:39. BioMed Central Full Text
• [19]Pickard AS, Yang Y, Lee TA: Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011, 9:26. BioMed Central Full Text
• [20]Singh SJ, Sodergren SC, Hyland ME, Williams J, Morgan MD: A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med 2001, 95:71-77.
• [21]Dolan P: Modeling valuations for EuroQol health states. Med Care 1997, 35:1095-1108.
• [22]Hawthorne G, Richardson J, Osborne R: The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999, 8:209-224.
• [23]Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, Jackson B, McDonald CF: A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 2011, 66:32-37.
• [24]Ware JE, Snow KK, Kosinski M: SF-36 health survey manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center Hospitals; 1993.
• [25]Benzo R, Flume PA, Turner D, Tempest M: Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil 2000, 20:231-234.
• [26]Mahler DA, Mackowiak JI: Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995, 107:1585-1589.
• [27]Mazur W, Kupiainen H, Pitkaniemi J, Kilpelainen M, Sintonen H, Lindqvist A, Kinnula VL, Laitinen T: Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD. Health Qual Life Outcomes 2011, 9:4.
• [28]Tsukino M, Nishimura K, McKenna SP, Ikeda A, Hajiro T, Zhang M, Izumi T: Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease. Respiration 2002, 69:513-520.
• [29]Janssen DJ, Wouters EF, Schols JM, Spruit MA: Self-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol. BMC Palliat Care 2008, 7:5. BioMed Central Full Text
• [30]Janssen DJ, Franssen FM, Wouters EF, Schols JM, Spruit MA: Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Qual Life Res 2011, 20:1679-1688.
• [31]Janssen DJ, Spruit MA, Schols JM, Cox B, Nawrot TS, Curtis JR, Wouters EF: Predicting changes in preferences for life-sustaining treatment among patients with advanced chronic organ failure. Chest 2012, 141:1251-1259.
• [32]Janssen DJ, Spruit MA, Uszko-Lencer NH, Schols JM, Wouters EF: Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med 2011, 14:735-743.
• [33]Janssen DJ, Spruit MA, Schols JM, Wouters EF: A call for high-quality advance care planning in outpatients with severe COPD or chronic heart failure. Chest 2011, 139:1081-1088.
• [34]Janssen DJ, Spruit MA, Wouters EF, Schols JM: Family Caregiving in Advanced Chronic Organ Failure. J Am Med Dir Assoc 2012, 13:394-399.
• [35]Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
• [36]American Thoracic Society: Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152:1107-1136.
• [37]Wilson RC, Jones PW: A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) 1989, 76:277-282.
• [38]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
• [39]Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
• [40]Hawthorne G, Osborne R: Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health 2005, 29:136-142.
• [41]Kruijshaar ME, Hoeymans N, Bijl RV, Spijker J, Essink-Bot ML: Levels of disability in major depression: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). J Affect Disord 2003, 77:53-64.
• [42]Juniper E, Guyatt G, Jaeschke R: How to develop and validate a new health-related quality of life instrument. In Quality of life and pharmacoeconomics in Clinical Trials. 2 edition. Edited by Spiker B. Philadelphia: Lippincott-Raven; 1996:49-56.
• [43]Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1997, 33:159-174.
• [44]Altman DG, Bland JM: Statistics notes: the normal distribution. BMJ 1995, 310:298.
• [45]Katsura H, Yamada K, Kida K: Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2003, 51:1131-1135.
• [46]Holland R, Smith RD, Harvey I, Swift L, Lenaghan E: Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ 2004, 13:793-805.
• [47]Coultas D, Frederick J, Barnett B, Singh G, Wludyka P: A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest 2005, 128:2017-2024.
• [48]Elci A, Borekci S, Ovayolu N, Elbek O: The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary-care community hospital. Respirology 2008, 13:703-707.
• [49]Katsura H, Yamada K, Kida K: Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005, 99:624-630.
• [50]Ritva K, Pekka R, Harri S: Agreement between a generic and disease-specific quality-of-life instrument: the 15D and the SGRQ in asthmatic patients. Qual Life Res 2000, 9:997-1003.
• [51]Pakhale S, Wood-Dauphinee S, Spahija J, Collet JP, Maltais F, Bernard S, Baltzan M, Rouleau M, Bourbeau J: Combining Both Generic and Disease-Specific Properties: Development of the McGill COPD Quality of Life Questionnaire. COPD: Journal of Chronic Obstructive Pulmonary Disease 2011, 8:255-263.
• [52]Barnes S, Gott M, Payne S, Parker C, Seamark D, Gariballa S, Small N: Recruiting older people into a large, community-based study of heart failure. Chronic Illn 2005, 1:321-329.
• [53]Steinhauser KE, Clipp EC, Hays JC, Olsen M, Arnold R, Christakis NA, Lindquist JH, Tulsky JA: Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006, 20:745-754.
• [54]McHorney CA, Tarlov AR: Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995, 4:293-307.
• [55]Perneger TV: What’s wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.